1. Hallek, M, Chronic lymphocytic leukemia: 2013 update on prognosis, risk stratification and treatment, Am. J. Hematol., 2013, vol. 88, no. 9, pp. 803–816.
2. WHO Classification of Tumor Haematopoietic and Lymphoid Tissues, Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J., and Vardiman, J.W., Eds., Lyon: International Agency for Research Cancer, 2008.
3. Oscier, D, Chronic lymphocytic leukemia. Do we need novel prognostic markers?, in Hematology Education: The Education Program for the Annual Congress of the European Hematology Association, 2013, vol. 7, pp. 121–130.
4. Shahjahani, M., Mohammadiasl, J., Noroozi, F., Seghatoleslami, M., Shahrabi, M., Saba, F., and Saki, N, Molecular basis of chronic lymhocytic leukemia diagnosis and prognosis, Cell. Oncol. (Dordr.), 2015, vol. 38, no. 2, pp. 93–109.
5. Meloni-Ehring, A., Gersen, S.L., and Keagle, M.B., The Cytogenetics of Hematologic Neoplasms. The Principles of Clinical Cytogenetics, 3rd ed., New York: Spinger,2013.